首页> Healthcare (Basel, Switzerland)> Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.

Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Najla,Bawazeer

第一单位： Department of Pharmacy, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia.

作者： Najla,Bawazeer ^[1] ; Seham,Bin Ganzal ^[1] ; Huda F,Al-Hasinah ^[1] ; Yazed,Alruthia ^[2]

作者单位： Department of Pharmacy, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia. ^[1] Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. ^[2]

关键词 Liraglutide Saudi Arabia Semaglutide cost-effectiveness diabetes obesity prediabetes

DOI 10.3390/healthcare13141755

PMID 40724780

发布时间 2025-08-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Healthcare (Basel, Switzerland)

2025年13卷14期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Healthcare (Basel, Switzerland)

2025年13卷14期

检索历史清除

Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.

Healthcare (Basel, Switzerland)

相似文献

同项目论文

Healthcare (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.

Healthcare (Basel, Switzerland)

相似文献

同项目论文

Healthcare (Basel, Switzerland)

相关期刊

检索历史清除